Trulicity .75 mg/.5mL (Dulaglutide INJECTION, SOLUTION) .75 mg/.5mL

Trulicity (Dulaglutide) is a subcutaneous injection used to manage type 2 diabetes. This solution comes in 0.75 mg/0.5 mL syringes, helping control blood sugar levels effectively.

Strength

.75 mg/.5mL

Pack Size

4 SYRINGE in 1 CARTON (0002-1433-80) / .5 mL in 1 SYRINGE (0002-1433-01)

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trulicity is primarily used to improve glycemic control in adults with type 2 diabetes. It works by mimicking natural hormones in your body to lower blood sugar levels. This medication is often part of a broader treatment plan that includes diet and exercise. People often ask, 'What is Trulicity used for?' It's designed to help manage diabetes when diet and exercise alone are not sufficient.

Side Effects

Common effects of Trulicity may include nausea, diarrhea, vomiting, and abdominal pain. Some users also experience decreased appetite and fatigue. These effects can vary and may not affect everyone who uses this medication.

Precautions & Warnings

Trulicity should be stored at room temperature and protected from light. It is important to follow the instructions for subcutaneous administration carefully. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

Trulicity may interact with other medications, including insulin and drugs that affect blood sugar levels. It is also important to be cautious when using alcohol while on this medication. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Trulicity is used to improve glycemic control in adults with type 2 diabetes as part of a comprehensive treatment plan.

Trulicity is administered subcutaneously, typically once weekly. Follow the instructions provided by your healthcare provider.

Common side effects may include nausea, diarrhea, vomiting, and abdominal pain. These effects can vary among individuals.

Trulicity may be used in combination with other diabetes medications, but always consult your healthcare provider for personalized advice.

Trulicity should be stored at room temperature and protected from light. Follow the storage instructions provided with the medication.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.